A Randomized Controlled Study of Topical Benzoyl Peroxide with Oral Doxycycline Versus Topical Benzoyl Peroxide with Oral Lymecycline in Acne Vulgaris

Main Article Content

Rekha Gurunatham Ponnurangam
Sindhuja Ramasamy
Sridhar Venu
Jayakalyani Vijayananth

Keywords

acne vulgaris, lymecycline, doxycycline, Indian Association of Acne Grading

Abstract

Background: Acne vulgaris is a chronic inflammatory disease of pilosebaceous unit, which has a variable course, with acute or insidious onset, relapses and recurrences. It is one of the commonest disease of patients attending the dermatology clinic. Tetracyclines are the most common oral antibiotic  prescribed for acne vulgaris.


Aims: Our study aims to compare the efficacy of  topical 2.5% Benzoyl peroxide gel (BPO) with oral Doxycycline versus topical 2.5% Benzoyl peroxide gel with oral Lymecycline  in the treatment of acne vulgaris.


Methods:  The study included 100 patients with acne vulgaris divided into two groups of 50 each. Group A were treated with topical 2.5% Benzoyl peroxide gel once daily application at night and capsule Doxycycline 100mg twice a day and Group B were treated with topical 2.5% Benzoyl Peroxide gel once daily application at night and capsule Lymecycline 408 mg once a day for 12 weeks.  The primary assessment was  done using Indian Association of Acne (IAA) grading at baseline and then every fortnight till 12 weeks. Patients were followed up for another 12 weeks after completion of the study.


Results: The gradewise distribution of acne based upon IAA grading among both the groups were compared. Chi square test and p value for all 3 grades of acne at baseline, 2week, 4 week, 6 week, 8 week, 10 week, 12 week showed statistical improvement among patients in group B at 2, 8 and 10 weeks with p value being 0.01,0.01 and 0.007 respectively.


Conclusions: From our study it is evident that  Lymecycline is superior to Doxycycline, with much statistical significance among moderate to severe acne.

References

1. Stern S. Dermatologists and office‐based care of dermatologist disease in the 21st century. J Invest Dermatol Symp Proc 2004;9:126–30.

2. Cooper AJ, Harris VR. Modern management of acne. Med J Aust. 2017 Jan 16;206(1):41-45

3. Agwuh KN, MacGowan A. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother. 2006;58(2):256–265.

4. Saleha T, Syed Faheem A R, Ummar A. Tetracycline: Classification, Structure Activity Relationship and Mechanism of Action as a Theranostic Agent for Infectious Lesions-A Mini Review. Biomed J Sci&Tech Res 7(2)- 2018. BJSTR. MS.ID.001475.

5. PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004-. PubChem Compound Summary for CID 54707177, Lymecycline; Available from : https://pubchem.ncbi.nlm.nih.gov/compound/Lymecycline

6. Dubertret L, Alirezai M, Rostain G, Lahfa M, Forsea D, Niculae BD, Simola M, Horvath A, Mizzi F. The use of lymecycline in the treatment of moderate to severe acne vulgaris: a comparison of the efficacy and safety of two dosing regimens. Eur J Dermatol. 2003 Jan-Feb;13(1):44-8.

7. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012 Jan 28;379(9813):361-72. doi: 10.1016/S0140-6736(11)60321-8. Epub 2011 Aug 29. Erratum in: Lancet. 2012 Jan 28;379(9813):314.

8. Dutil M. Benzoyl peroxide: enhancing antibiotic efficacy in acne management. Skin Therapy Lett. 2010 Nov-Dec;15(10):5-7.

9. Bossuyt L, Bosschaert J, Richert B et al. Lymecycline in the treatment of acne: an efficacious, safe and cost-effective alternative to minocycline. Eur J Dermatol. 2003;13(2):130–135.

10. M. Bjellerup, B. Ljunggren. Differences in phototoxic potency : A study on doxycycline and lymecycline in human volunteers, using an objective method for recording erythema.Br J Dermatol. 1994 Mar;130(3):356-60.